Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Sepsis × Colistin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sepsis 1 Neutropenia 1 Neoplasms 1

Interventions

Gentamicins 1 Colistin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01931592 2017-05-08

CLEAR

University of Cologne

Phase 2/3 Terminated

Neoplasms, Neutropenia, Sepsis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡